哌醋甲酯
心理学
随机对照试验
注意缺陷多动障碍
单盲板
替代(逻辑)
临床心理学
精神科
医学
内科学
计算机科学
程序设计语言
作者
Thomas J. Spencer,Eric O. Mick,Craig Bruce Hackett Surman,Paul Graves Hammerness,Robert Doyle,Megan Aleardi,Meghan Kotarski,Courtney G. Williams,Joseph Biederman
标识
DOI:10.1177/1087054710367880
摘要
OBJECTIVE: The main aim of this study was to examine the efficacy, tolerability, and compliance of an extended-release formulation of methylphenidate (OROS-MPH) in adults with ADHD receiving immediate-release methylphenidate (IR-MPH). METHOD: Participants were outpatient adults with ADHD who were stable on IR-MPH-administered TID. Participants were randomized (4:1) to equipotent doses of OROS-MPH or to continue IR-MPH and were assessed weekly for 6 weeks with the Adult ADHD Investigator System Symptom Report Scale (AISRS). RESULTS: Randomization of 53 IR-MPH responders to IR- or OROS-MPH had no effect on AISRS score at endpoint (11.2 ± 6.9 vs. 10.7 ± 5.1, p = .8). Participants stabilized on IR-MPH and switched to OROS-MPH remained satisfied over 71% of the time. However, the IR-MPH group missed more doses (7.3 ± 6.8 vs. 3.3 ± 4.2, p = .02) than the OROS-MPH group. CONCLUSION: Findings showed that adults with ADHD can be successfully switched from an effective regimen of IR-MPH TID to once-daily OROS-MPH. Results also demonstrated better compliance with OROS-MPH than with IR-MPH treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI